Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus | NEJM

preview_player
Показать описание
Iberdomide is an investigational drug that promotes degradation of two zinc finger transcription factors affecting immune cells that are overexpressed in systemic lupus erythematosus. New research findings are summarized in a short video.

  1. NEJM Group
  2. NEJM Group
  3. NEJM
  4. The New England Journal of Medicine
  5. medical research
Рекомендации по теме
Phase 2 Trial 0:01:59

Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus | NEJM

A Phase I/II 0:02:28

A Phase I/II trial of iberdomide for the treatment of intermediate- or high-risk smoldering myeloma

Iberdomide (CC-220) for 0:01:54

Iberdomide (CC-220) for R/R myeloma: updated trial results

Iberdomide Maintenance Therapy 0:05:41

Iberdomide Maintenance Therapy after ASCT in Myeloma | Tanye Wildes, MD | IMS 2024

First clinical study 0:02:12

First clinical study of iberdomide, a CELMoD, in pts with relapsed/refractory multiple myeloma

Iberdomide plus dexamethasone 0:02:42

Iberdomide plus dexamethasone for heavily pretreated multiple myeloma

Response Rate on 0:07:18

Response Rate on Phase 1/2 Trial REGN5458 (BCMAxCD3 Bispecific Antibody) for RRMM Patients

Results of Iberdomide 0:06:14

Results of Iberdomide in Combination with Dex and Daratumumab or Bortezomib in Patients with RRMM

Achieving MRD Negativity: 0:02:55

Achieving MRD Negativity: Iberdomide Study for Myeloma Post-AHCT | Natalie Callander, MD | #ASH24

Discussing Lupus: Iberdomide 0:19:34

Discussing Lupus: Iberdomide in CLE, and SGLT2i vs. DPP4i in SLE and comorbid type 2 diabetes

Results of ELOQUENT-2 0:02:00

Results of ELOQUENT-2 trial for treatment multiple myeloma

Iberdomide in Combination 0:04:45

Iberdomide in Combination with DEX in pts with RRMM: Results from the CC-220-MM-001 Trial

Iberdomide: A Novel 0:02:59

Iberdomide: A Novel Drug for Lupus: Dr. Kathryn Dao

Iberdomide in Combination 0:03:11

Iberdomide in Combination with Dex and Dara, Bort, or Cfz in Pts with RRMM

Iberdomide with cyclophosphamide 0:02:02

Iberdomide with cyclophosphamide and dexamethasone in RRMM: first results from the ICON study

2019 Multiple Myeloma 0:44:44

2019 Multiple Myeloma Symposium | Novel and Next Generation Therapy

Relapsed Multiple Myeloma: 0:02:54

Relapsed Multiple Myeloma: Iberdomide and CC-480 CELMoDs

ASH23: Iberdomide Maintenance 0:08:37

ASH23: Iberdomide Maintenance in EMN26 Study Post Stem-Cell Transplant | Neils van de Donk, MD, PhD

MagnetisMM-30, a Phase 0:04:36

MagnetisMM-30, a Phase 1b Study of ELRA and IBER Combination in Relapsed Refractory Multiple Myeloma

Iberdomide plus dex 0:02:54

Iberdomide plus dex effective and well tolerated in R/R MM

Cereblon modulators: a 0:12:22

Cereblon modulators: a new class of myeloma therapy — Dr. Sagar Lonial | MCRT Webcast August 22

Iberdomide in combination 0:02:04

Iberdomide in combination with dexamethasone for multiple myeloma

Iberdomide with dexamethasone 0:01:40

Iberdomide with dexamethasone for R/R multiple myeloma

CC-220-MM-001: IberDd, IberVd 0:01:32

CC-220-MM-001: IberDd, IberVd and IbrKd for R/R myeloma